Unknown

Dataset Information

0

Design, Biological Evaluation, and Computer-Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents.


ABSTRACT: Chlamydia trachomatis (CT) causes the most prevalent sexually transmitted bacterial disease in the United States. The lack of drug selectivity is one of the main challenges of the current antichlamydial pharmacotherapy. The metabolic needs of CT are controlled, among others, by cylindrical proteases and their chaperones (e.g., ClpX). It has been shown that dihydrothiazepines can disrupt CT-ClpXP. Based on this precedent, we synthesized a dihydrothiazepine library and characterized its antichlamydial activity using a modified semi-high-throughput screening assay. Then, we demonstrated their ability to inhibit ClpX ATPase activity in vitro, supporting ClpX as a target. Further, our lead compound displayed a promising selectivity profile against CT, acceptable cytotoxicity, no mutagenic potential, and good in vitro stability. A two-dimensional quantitative structure-activity relationship (2D QSAR) model was generated as a support tool in the identification of more potent antichlamydial molecules. This study suggests dihydrothiazepines are a promising starting point for the development of new and selective antichlamydial drugs.

SUBMITTER: de Campos LJ 

PROVIDER: S-EPMC10056257 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design, Biological Evaluation, and Computer-Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents.

de Campos Luana Janaína LJ   Seleem Mohamed A MA   Feng Jiachen J   Pires de Oliveira Kelly Mari KM   de Andrade Dos Santos João Víctor JV   Hayer Shivdeep S   Clayton Jonathan B JB   Kathi Sharvath S   Fisher Derek J DJ   Ouellette Scot P SP   Conda-Sheridan Martin M  

Journal of medicinal chemistry 20230125 3


<i>Chlamydia trachomatis</i> (CT) causes the most prevalent sexually transmitted bacterial disease in the United States. The lack of drug selectivity is one of the main challenges of the current antichlamydial pharmacotherapy. The metabolic needs of CT are controlled, among others, by cylindrical proteases and their chaperones (<i>e.g.</i>, ClpX). It has been shown that dihydrothiazepines can disrupt CT-ClpXP. Based on this precedent, we synthesized a dihydrothiazepine library and characterized  ...[more]

Similar Datasets

| S-EPMC11191600 | biostudies-literature
| S-EPMC10044843 | biostudies-literature
| S-EPMC7294690 | biostudies-literature
| S-EPMC3449398 | biostudies-literature
| S-EPMC5114837 | biostudies-literature
| S-EPMC6440409 | biostudies-literature
| S-EPMC9838881 | biostudies-literature
| S-EPMC5857607 | biostudies-literature
| S-EPMC5742826 | biostudies-literature
| S-EPMC6919621 | biostudies-literature